USPTO serial 97481798
LEAL HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2024
- Examiner
- LAWRENCE, SUSAN KASTRINER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LEAL HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole Kinsley, Esq.
Nicole Kinsley, Esq. FOLEY HOAG LLP155 SEAPORT BOULEVARDBOSTON, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials and approved drugs, biologic preparations, and medical devices, namely, management and compilation of computerized databases in the field of clinical trials and approved drugs, biologic preparations, and medical devices for business purposes; Recruitment advertising services, namely, distributing information about clinical trials for the purpose of recruiting patients for participation in clinical trials; advertising and promotional services, namely, assisting pharmaceutical, biolotechnology, and medical device companies in identifying patients who are good candidates for clinical trials or for approved drugs, biologic preparations, or medical devices, for purposes of improving marketing effectiveness; Business consulting and management in the field of clinical trials, namely, compiling and analyzing clinical and patient data for purposes of improving clinical trial operation, design, and patient enrollment; Business consulting and management in the field of drugs, biologic preparations, and medical devices, namely, compiling and analyzing clinical and patient data for purposes of improving marketing effectiveness by matching patients to appropriate treatment options; Business consulting and management in the field of clinical trials and approved drugs, biologic preparations, and medical devices, namely, providing information on patient population data and patient enrollment; Business consulting services, namely, providing assistance to medical personnel in the identification, recruitment, and enrollment of subjects for medical and scientific research and clinical trials and studies; Recruitment and enrollment of subjects for medical and scientific research and clinical trials and studies; Collection and analysis of patient data for business purposes; Business consulting and management in the field of clinical trials and approved drugs, biologic preparations, and medical devices, namely, providing information management services; Maintaining a registry of patients, namely, compilation of patient information into computer databases for business purposes; Providing clinical trial data and patient data, and analysis of such data, all for use in clinical trial recruitment of patients for clinical trials, and in improving the effectiveness of marketing efforts for approved drugs, biologic preparations, and medical devices; Consulting services in the field of patient identification for the purpose of recruitment for clinical trials and of improving the effectiveness of marketing efforts for approved drugs, biologic preparations, and medical devices | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials; Software as a service (SAAS) services featuring software for matching cancer patients with appropriate therapeutic options and clinical trials; Software as a service (SaaS) services featuring software for use in database management in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials; Software as a service (SaaS) services featuring software for management of clinical trials, namely, for planning clinical trials, identifying and recruiting patients for participation in clinical trials, and matching patients with clinical trials; Software as a service (SaaS) services featuring software for collecting, managing, and analyzing pharmaceutical data, biologic data, medical device data, and clinical trial data; Providing pharmaceutical data, biologic data, medical device data, clinical trial data, and patient data, and analysis of such data, all for pharmaceutical research and development; Consulting services in the field of design, planning, and implementation of clinical trials | ACTIVE | — |
| 044 | Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible therapies available, through medication, biologic preparations, medical devices, and clinical trials, for a defined set of symptoms, diagnoses, and biological attributes; providing medical information in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Trialmatch.me, Inc.
- Other trademarks owned by Trialmatch.me, Inc.
- Other trademarks owned by Trialmatch.me, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LEAL HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 27, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 21, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 21, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 2, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jan 2, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 18, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 30, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 30, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 30, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 14, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 14, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 14, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 14, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2022 | NWAP | NEW APPLICATION ENTERED | — |